Where is Pfizer Inc. (PFE) Headed?
Pfizer Inc. (NYSE:PFE) is one of the best immunotherapy stocks to buy according to hedge funds. On February 12, Daiwa downgraded Pfizer Inc.
Posts Tagged ‘Pfizer Inc (NYSE:PFE)’
12 Best Affordable Stocks Under $40 to Buy
On February 17, Jeremy Siegel, professor emeritus of finance at the University of Pennsylvania’s Wharton School of Business, appeared on a CNBC television interview to talk...
12 Best Immunotherapy Stocks to Buy According to Hedge Funds
On February 13, Matt Orton, Raymond James Investment Management's chief market strategist, appeared on CNBC’s ‘The Exchange’ to talk about the recent trends in equity markets...
Daiwa Downgrades Pfizer (PFE) to Neutral Following Full-Year 2025 Earnings
Pfizer Inc. (NYSE:PFE) is one of the most promising low-cost stocks to buy now.
Is Pfizer Inc. (PFE) One of the Best Medical Research Stocks to Buy According to Hedge Funds?
Pfizer Inc. (NYSE:PFE) is one of the best medical research stocks to buy according to hedge funds. Pfizer Inc. (NYSE:PFE) announced on February 6 that the U.S.
11 Most Promising Low-Cost Stocks to Buy Now
On February 7, Richard Bernstein, CEO of Richard Bernstein Advisors, joined 'The Exchange' on CNBC to discuss the state of equity markets, assessing which stocks are growing fast...
10 Best Medical Research Stocks to Buy According to Hedge Funds
On January 27, Sarah James, Cantor Fitzgerald analyst, appeared on CNBC’s ‘Squawk on the Street’ to talk about the healthcare insurance sector and the stocks coming under...
Pfizer (PFE) Closes 2025 on Solid Note, Returns $9.8B to Shareholders
Pfizer Inc. (NYSE:PFE) reported its Q4 2025 results on February 3. The company posted revenue of $17.56 billion, falling slightly by 1.1% from a year earlier.
Pfizer Inc. (PFE) Announces FDA’s Grant of Priority Review for HYMPAVZI® (marstacimab) sBLA
Pfizer Inc. (NYSE:PFE) is one of the best healthcare stocks under $50 to invest in. Pfizer Inc. (NYSE:PFE) announced on February 6 that the U.S.
Dividend Champions, Contenders and Challengers list: 15 Highest Yielding Stocks
Dividend Champions are companies that have raised their dividends for at least 25 consecutive years and may not be part of the S&P 500.
12 Best Healthcare Stocks Under $50 to Invest In
On January 27, Jared Holz, healthcare equity strategist at Mizuho, appeared on CNBC’s 'Power Lunch' to talk about healthcare stocks and the new proposals around Medicare Advantage...
Pfizer (PFE) Announces Positive Phase 2b Results for Obesity Drug Showing 12.30% Weight Loss
Pfizer Inc. (NYSE:PFE) is one of the best large cap stocks to buy under $50.
10 Best Large Cap Stocks to Buy Under $50
On January 21, Liz Ann Sonders, Chief Investment Strategist at Schwab Center for Financial Research, appeared on CNBC to state that markets face instability marked by fading risk...
Goldman Sachs Maintains Neutral on Pfizer (PFE) Amid Rising Margin Pressure
Pfizer Inc. (NYSE:PFE) ranks among the stocks with the lowest forward PE ratios. On January 23, Goldman Sachs reaffirmed its Neutral rating and $26 price target on Pfizer Inc.
15 Stocks on Jim Cramer’s Recent Game Plan
Jim Cramer, the host of Mad Money, said on Friday that the stock market could be set up for a rebound this week if the largest companies set to report earnings come through with...
20 Stocks with the Lowest Forward PE Ratio
Stocks fell on January 30 as the technology sector remained weak, despite President Donald Trump's appointment of Kevin Warsh to lead the Federal Reserve.
Cantor Fitzgerald Raises Pfizer (PFE) PT to $27 Amid Shifting Obesity Data Focus
Pfizer Inc. (NYSE:PFE) is one of the most undervalued large cap stocks to invest in now.
15 Most Undervalued Large Cap Stocks to Invest In Now
On January 21, Morgan Stanley chairman and CEO Ted Pick joined CNBC's 'Squawk Box' to discuss the latest market trends and suggested that the corporate health of large cap companies...
Pfizer Inks $530M Deal for Novavax Matrix-M Adjuvant Technology to Boost Vaccine Pipeline
Pfizer Inc. (NYSE:PFE) is one of the best inexpensive stocks to buy now.
11 Best Inexpensive Stocks to Buy Now
On January 16, Saira Malik, Nuveen CIO, joined CNBC's 'Closing Bell' to discuss her belief that earnings would propel the market forward, but valuations could bring volatility...
Pfizer to Exit ViiV Healthcare as GSK and Shionogi Reshape Ownership
Reuters reported on January 20 that Britain’s GSK and Japan’s Shionogi said Pfizer Inc. (NYSE:PFE) will exit their HIV-focused joint venture, ViiV Healthcare.
Dividend Contenders List: Top 20 Stocks
Dividend contenders are companies that have raised their dividends every year for at least a decade, but have not yet reached 25 straight years of growth.
Pfizer (PFE) CEO Isn’t Ready For A Fight With RFK Jr., Says Jim Cramer
Pharma giant Pfizer Inc. (NYSE:PFE)’s shares are down by 4.7% over the past year and flat year-to-date.
Why Pfizer Inc. (PFE) is One of the Best Affordable Stocks Under $30
Pfizer Inc. (NYSE:PFE) is one of the best affordable stocks under $30. Pfizer Inc.
10 Stocks Jim Cramer Talked About
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed the impact of the Justice Department serving the Federal Reserve with grand jury subpoenas and threatening...
10 Best Affordable Stocks Under $30
On January 12, Emily Roland, Manulife John Hancock Investment Management, co-chief investment strategist, appeared on CNBC’s 'Squawk Box' to talk about the latest market trends...
UBS Likes Pfizer’s MTSR Obesity Deal but Stays Neutral on PFE
On January 7, UBS initiated coverage of Pfizer Inc. (NYSE:PFE) with a Neutral rating and a $25 price target.
13 Best Dividend Stocks Paying Over 6%
Dividend yield has always been a point of debate in the market. Many investors are naturally drawn to high yields, seeing them as an easy way to generate income.
Pfizer, Astellas Report Positive Phase 3 Trial Results for PADCEV Combination in Bladder Cancer Treatment
Pfizer Inc. (NYSE:PFE) is one of the most buzzing stocks to invest in according to hedge funds. Earlier on December 17, Astellas Pharma and Pfizer Inc.
14 Most Buzzing Stocks to Invest In According to Hedge Funds
On January 1, Ryan Detrick of Carson Group appeared on CNBC's 'Closing Bell Overtime' to talk about his bullish outlook for 2026.
Pfizer (PFE) Plans Price Increases on About 80 Medicines Despite Broader Pricing Deals
Pfizer Inc. (NYSE:PFE) is among the drugmakers planning to raise prices on some medicines starting January 1.
13 Best January Dividend Stocks to Invest In
Valuations have climbed to historically high levels as tech stocks stayed in favor.
Pfizer (PFE) Navigates Patent Losses With Strategic Cost Controls, BMO Capital Reaffirms Outperform Rating
Pfizer Inc. (NYSE:PFE) ranks among the best stocks under $25 to buy now.
15 Best Stocks Under $25 to Buy Now
Stock futures were marginally lower early December 29, as traders grabbed profits at record index levels and exited prominent technology names and precious metals following an...
Pfizer (PFE) Braces for Bumpy Years as Growth Pushed Out to 2029
On December 16, Pfizer Inc. (NYSE:PFE) said the next few years are expected to be bumpy, starting in 2026.
Here’s What Analysts Think About Pfizer Inc. (PFE)
Pfizer Inc. (NYSE:PFE) is one of the best affordable healthcare stocks to buy now. Scotiabank analyst Louise Chen reiterated a Buy rating on Pfizer Inc.
14 Best Pharma Dividend Stocks to Buy in 2026
For most drugmakers, the US is the largest single market. Prices there are often close to three times higher than in other developed countries.
10 Best Affordable Healthcare Stocks to Buy Now
On December 26, Bernstein analyst Lance Wilkes appeared on CNBC to talk about the outlook for the managed care providers in 2026, along with how the rising healthcare costs could...
BofA Trims Pfizer (PFE) PT as COVID-19 Sales Slide and Obesity Focus Shifts to Metsera
Pfizer Inc. (NYSE:PFE) is one of the best high volume stocks to buy right now.
10 Best High Volume Stocks to Buy Right Now
On December 17, Lori Calvasina, RBC Capital Markets head of US equity strategy research, joined 'Squawk Box' on CNBC to discuss what to expect from markets in 2026.
Jim Cramer Shed Light on These 22 Stocks
“Owning stocks, picking stocks, figuring out the odds of something good happening, all that is integral to the process of making money.
Pfizer (PFE) CEO’s Struggling Because Of “a Good Hand,” Says Jim Cramer
Pfizer Inc. (NYSE:PFE)’s shares are down by 5.90% year-to-date, and December has been a tumultuous month for them.
12 Stocks on Jim Cramer’s Radar
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed comments by Treasury Secretary Scott Bessent, where he remarked that he saw inflation in the US dropping...
Pfizer Inc (PFE) Rating Steady Amid Neutral Market Outlook and Pipeline Progress
On Friday, December 12, 2025, The Fly reported that Morgan Stanley maintained its Hold (Equal‑Weight) rating on PFE., while lowering the price target to $28 from a prior estimate...
9 Most Undervalued Pharma Stocks to Buy Right Now
The U.S. pharmaceutical industry in 2025 remains one of the nation’s most dynamic and profitable economic sectors.
Pfizer Inc. (PFE) Announces Results from the Phase 3 BASIS Study Evaluating HYMPAVZI
Pfizer Inc. (NYSE:PFE) is one of the best pharma stocks to invest in. Pfizer Inc.
11 Cheap NYSE Stocks to Buy Now
On December 9, Kevin Mahn from Hennion & Walsh and Victoria Greene from G Squared Private Wealth appeared on CNBC television for an interview to discuss their 2026 market outlook...
11 Best Pharma Stocks to Invest In
CNBC reported on December 1 that the UK and US governments reached a deal on drug pricing.
Analysts See 12% Upside To Pfizer Inc. (PFE)
Pfizer Inc. (NYSE:PFE) is among the Top 15 Lowest P/E Ratios of the S&P 500 in 2025.
Top 15 Lowest P/E Ratios of the S&P 500 in 2025
The S&P 500 index gained 0.19% on Friday, December 5, to close at 6,870.40, marking the fourth successive winning day for the broad market index, as investors responded positively...
Hedge Fund Resource Center
